Critical Review: Owens & Minor (OMI) & Its Rivals

Owens & Minor (NYSE:OMIGet Free Report) is one of 143 publicly-traded companies in the “MED PRODUCTS” industry, but how does it contrast to its peers? We will compare Owens & Minor to similar businesses based on the strength of its dividends, risk, valuation, institutional ownership, profitability, analyst recommendations and earnings.

Analyst Ratings

This is a breakdown of current ratings for Owens & Minor and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owens & Minor 1 2 2 0 2.20
Owens & Minor Competitors 757 3703 7485 281 2.60

Owens & Minor currently has a consensus price target of $11.60, suggesting a potential upside of 39.12%. As a group, “MED PRODUCTS” companies have a potential upside of 39.03%. Given Owens & Minor’s higher possible upside, research analysts plainly believe Owens & Minor is more favorable than its peers.

Institutional & Insider Ownership

98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 44.3% of shares of all “MED PRODUCTS” companies are owned by institutional investors. 3.7% of Owens & Minor shares are owned by insiders. Comparatively, 12.6% of shares of all “MED PRODUCTS” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Owens & Minor and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Owens & Minor -3.41% 17.09% 2.47%
Owens & Minor Competitors -73.31% -49.28% -12.99%

Volatility & Risk

Owens & Minor has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500. Comparatively, Owens & Minor’s peers have a beta of 0.69, suggesting that their average stock price is 31% less volatile than the S&P 500.

Valuation & Earnings

This table compares Owens & Minor and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Owens & Minor $10.70 billion -$362.69 million -1.76
Owens & Minor Competitors $2.76 billion $241.42 million 3.66

Owens & Minor has higher revenue, but lower earnings than its peers. Owens & Minor is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Owens & Minor beats its peers on 7 of the 13 factors compared.

About Owens & Minor

(Get Free Report)

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.